Organoid

Organoid designates a three-dimensional, self-organising cellular structure grown in vitro from stem cells or primary tissue cells that recapitulates key architectural, functional, and genetic features of native organs. These miniature organ-like systems mimic tissue complexity through multicellular composition, spatial organisation, and physiologically relevant signalling. Organoids can be derived from embryonic stem cells, induced pluripotent stem cells, or adult tissue stem cells, representing organs including intestine, liver, brain, pancreas, kidney, and lung.

The biopharmaceutical industry increasingly employs organoids for disease modelling, drug discovery, toxicity testing, and precision medicine applications. Patient-derived organoids retain genetic and phenotypic characteristics of the original tissue, enabling personalised drug response testing, particularly in oncology where tumour organoids support screening of targeted agents. Toxicity assessment uses organoids to evaluate organ-specific drug effects with improved human relevance compared to animal models. Technical challenges include variability in organoid formation, limited vascularisation, constraints on immune system integration, and standardisation across laboratories. As culture systems improve through microfluidics, co-culture with immune cells, and automation enabling high-throughput screening, organoids continue advancing as transformative tools bridging in vitro experimentation with in vivo-like complexity.